Litigation Details for City of Providence v. Bausch Health Companies Inc. (N.D. Cal. 2019)
✉ Email this page to a colleague
City of Providence v. Bausch Health Companies Inc. (N.D. Cal. 2019)
Docket | ⤷ Sign Up | Date Filed | 2019-09-18 |
Court | District Court, N.D. California | Date Terminated | 2020-04-09 |
Cause | 15:1 Antitrust Litigation | Assigned To | William Haskell Alsup |
Jury Demand | Plaintiff | Referred To | |
Patents | 6,340,475; 6,488,962; 6,635,280; 6,723,340; 7,780,987; 8,323,692 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in City of Providence v. Bausch Health Companies Inc.
Details for City of Providence v. Bausch Health Companies Inc. (N.D. Cal. 2019)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2019-09-18 | 1 | Complaint | ,340 (the “340 Patent”) that expires on Oct. 25, 2021, 6,340,475 25 (the “475 Patent”) that expired …Book patent (the ‘692 Patent), as well as two non-Orange Book listed patents 19 (the ‘667 Patent and U.S…Assertio listed 4 patents on the 500 mg formulation (U.S. Patent Nos. 6,488,962 (the “962 Patent”) that…manufacturer’s patents and patent information for accuracy or trustworthiness. In 6 listing patents and patent…listed patent(s) and/or the patent is 9 invalid and unenforceable. By simply listing the patents in the | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |